Source link : https://www.newshealth.biz/health-news/ema-says-dont-mix-mysimba-and-opioid-containing-meds/
The European Medicines Agency (EMA) has recommended strengthening existing advice to minimize the risks from interactions between Mysimba (naltrexone/bupropion; Orexigen Therapeutics Ireland Limited) and opioid-containing medicines. The recommendation followed a routine review of the safety of the weight loss medication. The EMA’s Committee for Medicinal Products for Human Use (CHMP) advised that opioid painkillers may […]
Author : News Health
Publish date : 2024-07-26 16:55:26
Copyright for syndicated content belongs to the linked Source.
Categories